866-997-4948(US-Canada Toll Free)

EpiCast Report: Endometriosis - Epidemiology Forecast to 2025

Published By :

GlobalData

Published Date : Nov 2016

Category :

Pharmaceutical

No. of Pages : 56 Pages

EpiCast Report: Endometriosis - Epidemiology Forecast to 2025

Summary

Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. The condition is often associated with severe dysmenorrhea, chronic pelvic pain, chronic fatigue, deep dyspareunia, ovulation pain, abnormal bleeding, and infertility. Endometriosis has the potential to disrupt the quality of life of women, leading to emotional distress, loss of work productivity, physical limitations, and social withdrawal.

This report also provides diagnosed incident and prevalent cases of endometriosis segmented by laparoscopy confirmation status (laparoscopy-confirmed or suspected without laparoscopy). The laparoscopy-confirmed diagnosed prevalent cases of endometriosis are further classified according to endometriosis staging system developed by the American Society for Reproductive Medicine (ASRM) into stage I (minimal), stage II (mild), stage III (moderate), and stage IV (severe). In addition, the laparoscopy-confirmed diagnosed prevalent cases of endometriosis are segmented by phenotypes into superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA), and deeply infiltrating endometriosis (DIE). The laparoscopy-confirmed diagnosed incident and laparoscopy-confirmed diagnosed prevalent cases of endometriosis are further segmented by age.

In the 7MM, GlobalData epidemiologists forecast that the laparoscopy-confirmed diagnosed incident cases of endometriosis will increase from 251,010 cases in 2015 to 253,620 cases in 2025 at an Annual Growth Rate (AGR) of 0.10%. In the 7MM, GlobalData epidemiologists forecast that the laparoscopy-confirmed diagnosed prevalent cases of endometriosis will increase from 6,160,839 cases in 2015 to 6,217,079 cases in 2025 at an AGR of 0.09%.

GlobalData epidemiologists utilized comprehensive, country-specific data from peer-reviewed journal articles, and primary research to arrive at a meaningful, in-depth analysis and forecast for laparoscopy-confirmed diagnosed incident cases of endometriosis, as well as laparoscopy-confirmed diagnosed prevalent cases of endometriosis. Finally, the same forecast methodology was used across the 7MM, thereby allowing for meaningful global comparisons of laparoscopy-confirmed diagnosed incident cases, and laparoscopy-confirmed diagnosed prevalent cases of endometriosis across these markets.

Scope

- The Endometriosis EpiCast Report provides an overview of the risk factors and global trends of endometriosis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the laparoscopy-confirmed diagnosed incident cases of endometriosis and a 10-year forecast of laparoscopy-confirmed diagnosed prevalent cases of endometriosis. Additional segmentations of patient populations are also available.
- The endometriosis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Endometriosis EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global endometriosis market.
- Quantify patient populations in the global endometriosis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for endometriosis therapeutics in each of the markets covered.
- Identify the distribution of endometriosis prevalent cases by phenotypes and stage.
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7
2 Epidemiology 8
2.1 Disease Background 8
2.2 Risk Factors and Comorbidities 10
2.3 Global Trends 10
2.3.1 US 12
2.3.2 5EU 12
2.3.3 Japan 13
2.4 Forecast Methodology 13
2.4.1 Sources Used Tables 16
2.4.2 Forecast Assumptions and Methods 20
2.4.3 Sources Not Used 28
2.5 Epidemiological Forecast for Endometriosis (2015-2025) 29
2.5.1 Diagnosed Incident Cases 29
2.5.2 Diagnosed Prevalent Cases 36
2.6 Discussion 43
2.6.1 Epidemiological Forecast Insight 43
2.6.2 Limitations of the Analysis 44
2.6.3 Strengths of the Analysis 45
3 Appendix 46
3.1 Bibliography 46
3.2 Physicians and Specialists Included in this Study 50
3.3 About the Authors 52
1.1.1 Epidemiologists 52
3.3.1 Reviewers 53
3.3.2 Global Director of Therapy Analysis and Epidemiology 53
3.4 About GlobalData 54
3.5 About EpiCast 54
3.6 Disclaimer 55

1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Endometriosis 10
Table 2: Stages of Endometriosis According to the American Society for Reproductive Medicine Criteria 14
Table 3: 7MM, Sources of Epidemiological Data Used for the Forecast of Laparoscopy Confirmed Diagnosed Incident Cases of Endometriosis 16
Table 4: 7MM, Sources of Epidemiological Data Used for the Forecast of Laparoscopy Confirmed Diagnosed Prevalent Cases of Endometriosis 17
Table 5: 7MM, Sources of Epidemiological Data Used for the Classification of Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis According to the ASRM Stages I-IV 18
Table 6: 7MM, Sources of Epidemiological Data Used for the Classification of Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis According to the Phenotype 19
Table 7: Sources Used to Forecast Laparoscopy Confirmation Status for Diagnosed Incident Cases and Diagnosed Prevalent Cases of Endometriosis 20
Table 8: 7MM, Sources Not Used in Epidemiological Analysis of Endometriosis 28
Table 9: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025 30
Table 10: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Women, N (Row %), 2015 32
Table 11: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025 36
Table 12: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Women, N (Row %), 2015 38
Table 13: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2016 51

1.2 List of Figures
Figure 1: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025 30
Figure 2: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis by Age Group, Women, N, 2015 33
Figure 3: 7MM, Age-Standardized Laparoscopy-Confirmed Diagnosed Incidence of Endometriosis (Cases per 100,000 Population), Ages 12-54 Years, Women, 2015 34
Figure 4: 7MM, Diagnosed Incident Cases of Endometriosis Segmented by Laparoscopy Confirmation Status, Ages 12-54 Years, Women, N, 2015 35
Figure 5: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025 37
Figure 6: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Women, N, 2015 39
Figure 7: 7MM, Age-Standardized Laparoscopy-Confirmed Diagnosed Prevalence of Endometriosis (%), Ages 12-54 Years, Women, 2015 40
Figure 8: 7MM, Diagnosed Prevalent Cases of Endometriosis Segmented by Laparoscopy Confirmation Status, Ages 12-54 Years, Women, N, 2015 41
Figure 9: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis Segmented by ASRM Disease Stages, Ages 12-54 Years, Women, N, 2015 42
Figure 10: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis Segmented by Phenotype, Ages 12-54 Years, Women, N, 2015 43

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *